"At Florida Cancer Affiliates, we are committed to providing you with the best and most advanced, complete care available. We begin by offering therapies proven to be effective and advanced diagnostic and treatment technologies. We continue by providing unprecedented access to new investigational drugs through clinical trials."

During the past decade, Ocala Oncology Center conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 45 clinical trials were completed, i.e. on average, 91.8% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 25 clinical trials were completed. i.e. 96.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ocala Oncology Center" #1 sponsor was "US Oncology Research" with 9 trials, followed by "Celgene" with 7 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored, "Novartis Pharmaceuticals" with 6 trials sponsored and "Eli Lilly and Company" with 6 trials sponsored. Other sponsors include 78 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ocala Oncology Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Sanofi" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Ocala Oncology Center" are "Breast Cancer" (13 trials), "Non-Small Cell Lung Cancer" (7 trials), "Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials) and "Metastatic Breast Cancer" (5 trials). Many other conditions were trialed in "Ocala Oncology Center" in a lesser frequency.

Most popular intervention types in "Ocala Oncology Center" are "Drug" (101 trials), "Other" (15 trials), "Biological" (12 trials), "Combination Product" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (12 trials), "Placebo" (11 trials), "Carboplatin" (9 trials), "Nivolumab" (8 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Ocala Oncology Center" are 91 trials for "All" genders, 15 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Ocala Oncology Center". undefined are not yet recruiting, 19 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Ocala Oncology Center, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Ocala Oncology Center, 13 "Phase 1" clinical trials were conducted, 50 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".